Raymond James Trust N.A. Zymeworks Inc. Transaction History

Raymond James Trust N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.0 - $16.98 $73,398 - $207,716	-12,233 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$15.19 - $29.33 $8,354 - $16,131	550 Added 4.71%	12,233 $200,000
Q3 2021 Oct 18, 2021	BUY	$27.35 - $37.28 $42,392 - $57,784	1,550 Added 15.3%	11,683 $339,000
Q2 2021 Jul 20, 2021	BUY	$26.5 - $38.23 $689 - $993	26 Added 0.26%	10,133 $352,000
Q1 2021 May 03, 2021	BUY	$29.83 - $56.81 $53,694 - $102,258	1,800 Added 21.67%	10,107 $319,000
Q3 2020 Oct 14, 2020	BUY	$29.21 - $46.58 $242,647 - $386,940	8,307 New	8,307 $387,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.